Review the current role of PSA biomarkers, strategies for increasing specificity of PSA testing, and offers expert advice for optimizing risk assessment protocols.

Addressing PSA Specificity Webinar

Each year almost 700,000 new cases of prostate cancer are diagnosed worldwide, and approximately 221,000 deaths occur annually due to prostate cancer. Siemens Healthcare Diagnostics offers a full menu of Prostate Specific Antigen (PSA) tests that aid in the detection, monitoring and management of prostate cancer. In addition to traditional PSA tests, the Siemens portfolio of PSA assays include unique Complexed PSA and Third Generation PSA assays that are alternatives to conventional testing.

Patients and Caregivers
Physicians
Laboratorians